SIGA Technologies Inc
Gesloten
SectorGezondheidszorg
4.3 -0.69
Overzicht
Wijziging aandelenprijs
24u
Min
4.27
Max
4.33
Inkomsten | -34M -3.5M |
|---|---|
Verkoop | 2.4M 6.2M |
K/W Sectorgemiddelde | 15.464 49.052 |
EPS | -0.048 |
Winstmarge | -55.334 |
Werknemers | 49 |
EBITDA | 4.3M -5.2M |
Volgende Winsten | 4 aug 2026 |
|---|
Marktkapitalisatie | -22M 311M |
|---|---|
Vorige openingsprijs | 4.99 |
Vorige sluitingsprijs | 4.3 |
Nieuwssentiment
By Acuity
89%
11%
323 / 342 Rangschikking in Healthcare
SIGA Technologies Inc Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Over SIGA Technologies Inc
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
